Literature DB >> 19479743

Brain-derived nerve growth factor in the treatment of sensorineural hearing loss.

Eric Meen1, Brian Blakley, Taeed Quddusi.   

Abstract

OBJECTIVES/HYPOTHESIS: A possible medical treatment for sensorineural hearing loss using brain-derived nerve growth factor (BDNF) was explored. The hypothesis is that direct intracochlear application of BDNF will result in improved hearing. STUDY
DESIGN: Animal research study.
METHODS: Significant hearing loss was created using cisplatin in 11 guinea pigs. One month later, bilateral cochleostomies were performed placing 0.05 microg of BDNF in one cochlea of each animal prior to plugging with connective tissue. The other cochlea served as a control. Auditory brain-stem response (ABR) testing was then carried out for three months at 6,000, 8,000, 12,000, and 24,000 Hz.
RESULTS: ABR thresholds were better in the treated ear for all frequencies. Threshold differences were statistically significantly better two months after treatment (general linear model, repeated measures P = .045).
CONCLUSIONS: Intracochlear application of BDNF may prevent hearing loss.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19479743     DOI: 10.1002/lary.20515

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  7 in total

1.  Brain-derived neurotrophic factor modulates auditory function in the hearing cochlea.

Authors:  David J Sly; Amy J Hampson; Ricki L Minter; Leon F Heffer; Jack Li; Rodney E Millard; Leon Winata; Allen Niasari; Stephen J O'Leary
Journal:  J Assoc Res Otolaryngol       Date:  2011-11-16

2.  Prevention of cisplatin-induced hearing loss by extended release fluticasone propionate intracochlear implants.

Authors:  Erik Pierstorff; Wan-Wan Yang; Yen-Jung Angel Chen; Shirley Cheung; Federico Kalinec; William H Slattery
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2019-03-20       Impact factor: 1.675

Review 3.  Cisplatin ototoxicity and protection: clinical and experimental studies.

Authors:  Leonard P Rybak; Debashree Mukherjea; Sarvesh Jajoo; Vickram Ramkumar
Journal:  Tohoku J Exp Med       Date:  2009-11       Impact factor: 1.848

4.  Expression of brain-derived neurotrophic factor and TrkB in the lateral line system of zebrafish during development.

Authors:  A Germanà; R Laurà; G Montalbano; M C Guerrera; V Amato; R Zichichi; S Campo; E Ciriaco; J A Vega
Journal:  Cell Mol Neurobiol       Date:  2010-02-17       Impact factor: 5.046

Review 5.  Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.

Authors:  Igor Khalin; Renad Alyautdin; Ganna Kocherga; Muhamad Abu Bakar
Journal:  Int J Nanomedicine       Date:  2015-04-30

6.  Brain-derived nerve growth factor in the cochlea - a reproducibility study.

Authors:  Brian W Blakley; Michael Seaman; Abdulrahman Alenezi
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-06-05

Review 7.  Use of the guinea pig in studies on the development and prevention of acquired sensorineural hearing loss, with an emphasis on noise.

Authors:  Gaëlle Naert; Marie-Pierre Pasdelou; Colleen G Le Prell
Journal:  J Acoust Soc Am       Date:  2019-11       Impact factor: 2.482

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.